文献速递冠心病外科

糖尿病患者外科血运重建术后的结局

Outcomes after surgical revascularization in diabetic patients.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

欧洲DuraGraft注册研究纳入1130例(44.6%)合并糖尿病与1402例(55.4%)不合并糖尿病的孤立性冠状动脉旁路移植术(CABG)患者,术中所有游离静脉和动脉移植物均经内皮损伤抑制剂处理。倾向性评分匹配后每组1072例,1年主要不良心血管事件(MACE)在两组间无统计学显著差异[7.1% vs 5.7%,HR 1.23(95%CI 0.87-1.74),P=0.23]。作者结论为糖尿病患者行孤立性CABG的1年结局与不合并糖尿病者相当。

要点

  • 匹配前糖尿病组1年MACE高于非糖尿病组[7.9% vs 5.5%,HR 1.43(95%CI 1.05-1.95),P=0.02]。
  • 匹配前死亡[5.6% vs 3.5%,HR 1.61(95%CI 1.10-2.36),P=0.01]与心肌梗死[2.8% vs 1.4%,HR 1.99(95%CI 1.12-3.53),P=0.02]均更高。
  • 倾向性评分匹配后MACE及其各组分在两组间无统计学显著差异。

核心结论

  • 本研究中糖尿病患者行孤立性CABG的1年结局与不合并糖尿病者相当。
  • 年龄、危重手术状态、心外动脉病变、射血分数≤50%和左主干病变被识别为MACE的独立预测因素,而糖尿病不是。

研究设计与样本

  • 欧洲DuraGraft注册研究,纳入1130例(44.6%)合并糖尿病与1402例(55.4%)不合并糖尿病的孤立性CABG患者。
  • 术中所有游离静脉和动脉移植物均经内皮损伤抑制剂处理。
  • 采用倾向性评分匹配平衡基线特征,每组1072例。
  • 采用多因素Cox比例风险回归识别MACE的独立预测因素。

主要发现

  • 糖尿病组心血管风险谱更高、EuroSCORE II更高且合并症总体更多。
  • 两组在手术技术和血运重建完全性方面相当。
  • 1年时糖尿病组MACE更高[7.9% vs 5.5%,HR 1.43(95%CI 1.05-1.95),P=0.02],由死亡[5.6% vs 3.5%,HR 1.61(95%CI 1.10-2.36),P=0.01]和心肌梗死[2.8% vs 1.4%,HR 1.99(95%CI 1.12-3.53),P=0.02]发生率升高驱动。
  • 倾向性评分匹配后MACE无统计学显著差异[7.1% vs 5.7%,HR 1.23(95%CI 0.87-1.74),P=0.23],其各组分亦无统计学显著差异。
  • 年龄、危重手术状态、心外动脉病变、射血分数≤50%和左主干病变被识别为MACE的独立预测因素,糖尿病不是。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients with diabetes mellitus (DM) undergoing coronary artery bypass grafting (CABG) have been repeatedly demonstrated to have worse clinical outcomes compared to patients without DM. The objective of this study was to evaluate the impact of DM on 1-year clinical outcomes after isolated CABG. METHODS: The European DuraGraft registry included 1130 patients (44.6%) with and 1402 (55.4%) patients without DM undergoing isolated CABG. Intra-operatively, all free venous and arterial grafts were treated with an endothelial damage inhibitor. Primary end point in this analysis was the incidence of a major adverse cardiac event (MACE), a composite of all-cause death, repeat revascularization or myocardial infarction at 1 year post-CABG. To balance between differences in baseline characteristics (n = 1072 patients in each group), propensity score matching was used. Multivariable Cox proportional hazards regression was performed to identify independent predictors of MACE. RESULTS: Diabetic patients had a higher cardiovascular risk profile and EuroSCORE II with overall more comorbidities. Patients were comparable in regard to surgical techniques and completeness of revascularization. At 1 year, diabetics had a higher MACE rate {7.9% vs 5.5%, hazard ratio (HR) 1.43 [95% confidence interval (CI) 1.05-1.95], P = 0.02}, driven by increased rates of death [5.6% vs 3.5%, HR 1.61 (95% CI 1.10-2.36), P = 0.01] and myocardial infarction [2.8% vs 1.4%, HR 1.99 (95% CI 1.12-3.53) P = 0.02]. Following propensity matching, no statistically significant difference was found for MACE [7.1% vs 5.7%, HR 1.23 (95% CI 0.87-1.74) P = 0.23] or its components. Age, critical operative state, extracardiac arteriopathy, ejection fraction ≤50% and left main disease but not DM were identified as independent predictors for MACE. CONCLUSIONS: In this study, 1-year outcomes in diabetics undergoing isolated CABG were comparable to patients without DM.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Misfeld M, Sandner S, Caliskan E, et al. Outcomes after surgical revascularization in diabetic patients. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38218725. doi:10.1093/icvts/ivae014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。